Anti-ovarian carcinoma anti-T3 heteroconjugates or hybrid antibodies induce tumor cell lysis by cytotoxic T-cells.

Source:http://linkedlifedata.com/resource/pubmed/id/3258291

Download in:

View as

General Info

PMID
3258291